
HEMAB THERAPEUTICS HOLDINGS
COAGNASDAQ๐ #1736 by market capUS Equity
$53.53โฒ $1.85 (+3.46%)
Live1hโฒ 3.2%
24hโฒ 3.5%
7dโฒ 7.3%
14dโฒ 19.7%
30dโฒ 34.7%
1yโ
๐ฆMarket Cap
$2.50B
Small Cap
๐Revenue Growth (YoY)
โ
๐Gross Margin
โ
๐ตFCF Margin
โ
โ๏ธP/S Ratio
โ
Otter Score
65
Fair
Earnings
Q3 ยท 2026Reported 2026-08-11Earnings Per Share
Actual
-0.80
Expected
-0.73
miss
โ9.20%
Revenue
Actual
โ
Expected
โ
โ
โ
Consensus estimates
Recent quarters
Q3 2026
-0.80
miss
Q2 2026
-23.98
miss